Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
Internet-Based Program to Improve Asthma Management in Children
This study is not yet open for participant recruitment.
Verified by National Heart, Lung, and Blood Institute (NHLBI), April 2007
Sponsored by: National Heart, Lung, and Blood Institute (NHLBI)
Information provided by: National Heart, Lung, and Blood Institute (NHLBI)
ClinicalTrials.gov Identifier: NCT00377663
  Purpose

Asthma is a respiratory condition that affects millions of children. It can be controlled, however, with the proper medications and treatment. AsthmaNet, an internet-based asthma management system, aims to improve the asthma care of children by providing their parents and doctors with appropriate tools and feedback related to asthma management. The purpose of this study is to evaluate the effectiveness of AsthmaNet at improving quality of care and controlling asthma symptoms in children.


Condition Intervention
Asthma
Behavioral: AsthmaNet

MedlinePlus related topics: Asthma
U.S. FDA Resources
Study Type: Interventional
Study Design: Treatment, Randomized, Single Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study
Official Title: Internet-Based Patient-Centered Asthma Management System

Further study details as provided by National Heart, Lung, and Blood Institute (NHLBI):

Primary Outcome Measures:
  • Appropriate use of asthma controller medications
  • Number of asthma symptom days (both measured at Year 1)

Estimated Enrollment: 600
Study Start Date: July 2007
Detailed Description:

In the United States, almost 9 million children have been diagnosed with asthma. It is a leading cause of hospitalization, chronic disease, and school absenteeism. With the proper treatment, most children with asthma are able to lead a normal life. However, if asthma is not adequately controlled, it can be a life-threatening disease. It is important for parents to work with their child’s doctor to develop a comprehensive treatment plan that minimizes asthma symptoms. AsthmaNet, an interactive web-based system, aims to improve the quality of care for children with asthma by enhancing parents’ asthma care skills and encouraging parents to discuss their child’s asthma care with their doctor. AsthmaNet provides evidence-based guidelines, asthma management tools, and individually tailored feedback to both parents and physicians to improve communication and enhance asthma management skills and behaviors. The goal of this study is to evaluate the effectiveness of AsthmaNet at increasing medication and treatment adherence in children with asthma.

This 1-year study will enroll young children with asthma. Participants will be randomly assigned to either use the AsthmaNet web site or not use the web site. The web site will provide parents of children in the AsthmaNet group with individualized clinical information regarding their child’s asthma care and with decision-making aids that they can share with their child’s doctor. The web site will also prompt parents to make additional doctor appointments, as needed, to discuss their child’s condition. All children will attend regularly scheduled doctor’s appointments for asthma and receive their usual care; there are no additional study visits specifically for this study. Study researchers will review medical records to analyze medication usage and asthma symptoms. Participants in the AsthmaNet group will complete questionnaires on a monthly basis to assess asthma status; the control group will complete questionnaires at Month 6 and Year 1.

  Eligibility

Ages Eligible for Study:   2 Years to 10 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Asthma
  • Receives asthma care at a clinic in Western Washington
  • Has access to the internet at home

Exclusion Criteria:

  • Does not speak or read English
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00377663

Contacts
Contact: Lyn Bassett, MA 206-616-9364 altal@u.washington.edu

Locations
United States, Washington
University of Washington
Seattle, Washington, United States, 98115
Sponsors and Collaborators
Investigators
Principal Investigator: Dimitri A. Christakis, MD, MPH University of Washington
  More Information

Study ID Numbers: 431, R01 HL079402-01A2
Study First Received: September 14, 2006
Last Updated: April 26, 2007
ClinicalTrials.gov Identifier: NCT00377663  
Health Authority: United States: Federal Government

Study placed in the following topic categories:
Hypersensitivity
Lung Diseases, Obstructive
Respiratory Tract Diseases
Lung Diseases
Hypersensitivity, Immediate
Asthma
Respiratory Hypersensitivity

Additional relevant MeSH terms:
Immune System Diseases
Bronchial Diseases

ClinicalTrials.gov processed this record on January 15, 2009